Integrative analyses of maternal plasma cell-free DNA nucleosome footprint differences reveal chromosomal aneuploidy fetuses gene expression profile

被引:7
|
作者
Zhang, Min [1 ]
Li, Kun [1 ]
Qu, Shoufang [2 ]
Guo, Zhiwei [1 ]
Wang, Yuanli [3 ]
Yang, Xu [1 ]
Zhou, Junhua [3 ]
Ouyang, Guojun [3 ]
Weng, Rongtao [3 ]
Li, Fenxia [4 ]
Wu, Yingsong [1 ]
Yang, Xuexi [1 ]
机构
[1] Southern Med Univ, Sch Lab Med & Biotechnol, Inst Antibody Engn, 1838 N Guangzhou Ave, Guangzhou 510515, Peoples R China
[2] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China
[3] Guangzhou Darui Biotechnol Co Ltd, Guangzhou 510665, Guangdong, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Peoples R China
关键词
Plasma cell free DNA; Aneuploid fetus; Trisomy pregnancy; Nucleosome footprints; Gene expression profiles; OF-FUNCTION MUTATIONS; FETAL DNA; MECHANISMS; SUPPRESSION; DISORDERS; FRACTION; DELETION; TISSUES; ROLES; SERUM;
D O I
10.1186/s12967-022-03735-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Chromosomal aneuploidy is the most common birth defect. However, the developmental mechanism and gene expression profile of fetuses with chromosomal aneuploidy are relatively unknown, and the maternal immune changes induced by fetal aneuploidy remain unclear. The inability to obtain the placenta multiple times in real-time is a bottleneck in research on aneuploid pregnancies. Plasma cell-free DNA (cfDNA) carries the gene expression profile information of its source cells and may be used to evaluate the development of fetuses with aneuploidy and the immune changes induced in the mother owing to fetal aneuploidy. Methods Here, we carried out whole-genome sequencing of the plasma cfDNA of 101 pregnant women carrying a fetus with trisomy (trisomy 21, n = 42; trisomy 18, n = 28; trisomy 13, n = 31) based on non-invasive prenatal testing (NIPT) screening and 140 normal pregnant women to identify differential genes according to the cfDNA nucleosome profile in the region around the transcription start sites (TSSs). Results The plasma cfDNA promoter profiles were found to differ between aneuploid and euploid pregnancies. A total of 158 genes with significant differences were identified, of which 43 genes were upregulated and 98 genes were downregulated. Functional enrichment and signaling pathway analysis were performed based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases found that these signal pathways were mainly related to the coordination of developmental signals during embryonic development, the control of cell growth and development, regulation of neuronal survival, and immune regulation, such as the MAPK, Hippo, TGF-beta, and Rap1 signaling pathways, which play important roles in the development of embryonic tissues and organs. Furthermore, based on the results of differential gene analysis, a total of 14 immune-related genes with significant differences from the ImmPort database were collected and analyzed. These significantly different immune genes were mainly associated with the maintenance of embryonic homeostasis and normal development. Conclusions These results suggest that the distribution characteristics of cfDNA nucleosomes in maternal plasma can be used to reflect the status of fetal development and changes of the immune responses in trisomic pregnancies. Overall, our findings may provide research ideas for non-invasive detection of the physiological and pathological states of other diseases.
引用
收藏
页数:12
相关论文
共 37 条
  • [21] Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup
    Yaron, Yuval
    Pauta, Montse
    Badenas, Celia
    Soler, Anna
    Borobio, Virginia
    Illanes, Carmen
    Paz-y-Mino, Fernanda
    Martinez-Portilla, Raigam
    Borrell, Antoni
    HUMAN REPRODUCTION, 2020, 35 (05) : 1222 - 1229
  • [22] Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-Invasive Prenatal Testing of Cell-Free DNA in Maternal Plasma for Detection of Fetal Aneuploidy
    Michaelson-Cohen, Rachel
    Gershoni-Baruch, Ruth
    Sharoni, Reuven
    Shochat, Mordechai
    Yaron, Yuval
    Singer, Amihood
    FETAL DIAGNOSIS AND THERAPY, 2014, 36 (03) : 242 - 244
  • [24] Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation
    Rodgers, Nicholas
    Gerding, Bryn
    Cusi, Vincenzo
    Vaida, Florin
    Tada, Yuko
    Morris, Gerald P.
    Adler, Eric D.
    Stehlik, Josef
    Kim, Paul J.
    CLINICAL TRANSPLANTATION, 2023, 37 (06)
  • [25] Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk
    Lopez, Sonia
    Martinez-Perez, Angel
    Rodriguez-Rius, Alba
    Vinuela, Ana
    Brown, Andrew A.
    Martin-Fernandez, Laura
    Vilalta, Noelia
    Arus, Marc
    Panousis, Nikolaos, I
    Buil, Alfonso
    Sabater-Lleal, Maria
    Carlos Souto, Juan
    Dermitzakis, Emmanouil T.
    Manuel Soria, Jose
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (06) : 1027 - 1039
  • [26] Preconditioning with Intravenous Colitic Cell-Free DNA Prevents DSS-Colitis by Altering TLR9-Associated Gene Expression Profile
    Muzes, Gyoergyi
    Sipos, Ferenc
    Furi, Istvan
    Constantinovits, Miklos
    Spisak, Sandor
    Wichmann, Barnabas
    Valcz, Gabor
    Tulassay, Zsolt
    Molnar, Bela
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (12) : 2935 - 2946
  • [27] Preconditioning with Intravenous Colitic Cell-Free DNA Prevents DSS-Colitis by Altering TLR9-Associated Gene Expression Profile
    Györgyi Műzes
    Ferenc Sipos
    István Fűri
    Miklós Constantinovits
    Sándor Spisák
    Barnabás Wichmann
    Gábor Valcz
    Zsolt Tulassay
    Béla Molnár
    Digestive Diseases and Sciences, 2014, 59 : 2935 - 2946
  • [28] Can Donor-Derived Cell-Free DNA or Gene Expression Profile Be Used to Monitor Response to Treatment After Subclinical Acute Rejection?
    Park, Sookhyeon
    Dietch, Zachary
    Guo, Kexin
    Zhao, Lihui
    Friedewald, John J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 672 - 672
  • [29] Race and Ethnic Differences in Donor-Derived Cell-Free DNA and Gene Expression Profiling in Heart Transplant Recipients in a Negative Biopsy Cohort
    Oren, Daniel
    Moeller, Cathrine
    Fernandez, Andrea Valledor
    Rahman, Salwa
    Rubinstein, Gal
    Baranowska, Julia
    Lotan, Dor
    DeFilippis, Ersilia
    Fried, Justin
    Yunis, Adil
    Raikhelkar, Jayant
    Clerkin, Kevi N.
    Peterson, Stephen J.
    Parikh, Manish
    Latif, Farhana
    Sayer, Gabriel
    Uriel, Nir
    CIRCULATION, 2024, 150
  • [30] A Case Report of a Feto-Placental Mosaicism Involving a Segmental Aneuploidy: A Challenge for Genome Wide Screening by Non-Invasive Prenatal Testing of Cell-Free DNA in Maternal Plasma
    De Falco, Luigia
    Vitiello, Giuseppina
    Savarese, Giovanni
    Suero, Teresa
    Ruggiero, Raffaella
    Savarese, Pasquale
    Ianniello, Monica
    Petrillo, Nadia
    Bruno, Mariasole
    Legnante, Antonietta
    Passaretti, Francesco Fioravanti
    Ardisia, Carmela
    Di Spiezio Sardo, Attilio
    Fico, Antonio
    GENES, 2023, 14 (03)